Cellebrite DI (CLBT) Is Down 11.7% After Strong 2025 Profit Rebound And 2026 Guidance Update - simplywall.st

Cellebrite DI Ltd. recently reported its fourth-quarter and full-year 2025 results, showing revenue rising to US$128.82 million for the quarter and US$475.68 million for the year, alongside a swing from a large prior-year loss to net income of US$78.33 million, and issued 2026 revenue guidance of US$126 million–US$128 million for Q1 and US$565 million–US$571 million for the full year. The move from a basic loss per share of US$1.35 in 2024 to basic earnings per share of US$0.32 in 2025 highlights a major shift in Cellebrite’s profitability profile, underscoring how its business model is currently translating higher revenue into positive earnings. With this earnings improvement and 2026 revenue guidance in mind, we’ll examine how Cellebrite’s updated outlook influences its existing investment narrative. Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.AdvertisementCellebrite DI Investment Narrative RecapTo own Cellebrite, you need to believe its digital intelligence tools can keep winning budget share with government and enterprise customers while staying ahead of tightening privacy rules and device security. The latest 2025 results and 2026 guidance point to continued revenue growth and sustained profitability, but they do not materially change the near term risk that U.S. federal spending delays and procurement bottlenecks could weigh on ARR and earnings. In that context, Cellebrite’s 2026 revenue guidance of US$565 million to US$571 million is especially relevant, because it frames how quickly management expects the business to scale after turning a US$283.01 million loss into US$78.33 million of net income in 2025. This outlook sits alongside recent analyst reactions, including target cuts despite strong ARR trends, highlighting how sensitive the near term catalyst is to any change in growth expectations. Yet behind the improving earnings, investors should still be aware that growing global privacy scrutiny could eventually... Read the full narrative on Cellebrite DI (it's free!)Cellebrite DI's narrative projects $671.4 million revenue and $128.8 million earnings by 2028. This requires 15.4% yearly revenue growth and a $279.7 million earnings increase from -$150.9 million today.Uncover how Cellebrite DI's forecasts yield a $21.67 fair value, a 72% upside to its current price.Exploring Other PerspectivesCLBT 1-Year Stock Price Chart Some of the most optimistic analysts were previously modeling revenue near US$735 million and earnings above US$200 million, which is far more bullish than the cautious view around regulatory and privacy risks. As you look at this new guidance and the 2025 profit swing, it is worth asking whether those upbeat projections still hold or if both optimistic and conservative narratives need a rethink.Explore 7 other fair value estimates on Cellebrite DI - why the stock might be worth over 2x more than the current price!Form Your Own VerdictDisagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.A great starting point for your Cellebrite DI research is our analysis highlighting 4 key rewards that could impact your investment decision.Our free Cellebrite DI research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Cellebrite DI's overall financial health at a glance.Ready For A Different Approach?The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:Capitalize on the AI infrastructure supercycle with our selection of the 34 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.Find 51 companies with promising cash flow potential yet trading below their fair value.Uncover the next big thing with 31 elite penny stocks that balance risk and reward. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.comAbout NasdaqGS:CLBTCellebrite DIDevelops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.See The Free Research ReportFlawless balance sheet and fair value.See The Free Research ReportSimilar CompaniesNasdaqGS:ROPRoper TechnologiesNYSE:TYLTyler TechnologiesMarket InsightsWhat the next 25 years will look like 🔮Richard BowmanThree contrarian investing ideas for a new marketStella Ong Alternatives part 2: 2026 and beyond 🔭Richard BowmanAdvertisementWeekly PicksVAvaluebull on Eva Live · 13 days agoIs this the AI replacing marketing professionals? Fair Value:US$7.4342.5% undervalued29 followersusers have followed this narrative·0 commentsusers have commented on this narrative·5 likesusers have liked this narrativeZAZayaanS on Pro Medicus · 9 days agoPro Medicus: The Market Is Confusing a Lumpy Quarter With a Broken BusinessFair Value:AU$196.7833.2% undervalued31 followersusers have followed this narrative·5 commentsusers have commented on this narrative·18 likesusers have liked this narrativeSTSteveGruber on Warner Bros. Discovery · 8 days agoThe Rising Deal Risk That Helped Sink Netflix’s $72 Billion Bid for Warner Bros. Discovery  Fair Value:US$18.1752.7% overvalued5 followersusers have followed this narrative·1 commentusers have commented on this narrative·3 likesusers have liked this narrativePDpdixit1 on Vertiv Holdings Co · 12 days agoThe Infrastructure AI Cannot Be Built WithoutFair Value:US$408.6435.3% undervalued35 followersusers have followed this narrative·3 commentsusers have commented on this narrative·17 likesusers have liked this narrativeRecently Updated NarrativesVEVestra on Circle Internet Group · about 2 hours agoCircle Internet Group (CRCL): The Programmable Dollar Powerhouse – Post-IPO Momentum and Stablecoin Dominance.Fair Value:US$1206.8% undervalued1 followerusers have followed this narrative·0 commentsusers have commented on this narrative·0 likesusers have liked this narrativeVEVestra on TTM Technologies · about 2 hours agoTTM Technologies (TTMI): The Backbone of the AI Tsunami and Defense Modernization.Fair Value:US$119.7319.2% undervalued1 followerusers have followed this narrative·0 commentsusers have commented on this narrative·0 likesusers have liked this narrativeVEVestra on Bloom Energy · about 2 hours agoBloom Energy Corp (BE): The AI "Bridge-to-Power" – Scaling to 2GW Capacity for the Next-Gen Data Center.Fair Value:US$160.65.8% undervalued1 followerusers have followed this narrative·0 commentsusers have commented on this narrative·0 likesusers have liked this narrativePopular NarrativesKAkabz2342 on Nu Holdings · 16 days agoNu holdings will continue to disrupt the South American banking marketFair Value:US$64.377.2% undervalued51 followersusers have followed this narrative·3 commentsusers have commented on this narrative·27 likesusers have liked this narrativeANAnalystConsensusTarget on NVIDIA · 2 months agoNVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026Fair Value:US$253.0227.8% undervalued1102 followersusers have followed this narrative·7 commentsusers have commented on this narrative·34 likesusers have liked this narrativeANAnalystConsensusTarget on Microsoft · 5 days agoAnalyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive RisksFair Value:US$59631.3% undervalued1302 followersusers have followed this narrative·2 commentsusers have commented on this narrative·10 likesusers have liked this narrativeTrending DiscussionUSUser on Pro Medicus · 6 days agoThanks for a well considered analysis that helps a buy/hold/sell decision.2|0TETemujinBC on Cassiar Gold · 2 days agoPretty fantastic Friday for Cassiar stock. Onward we go1|0USUser on Pro Medicus · 6 days agoThe actual P/E ratio is close to 90x because the profit generated by 4D Medical should not be taken...1|0